XDEMVY approved for the treatment of Demodex blepharitis
Jul 25, 2023 at 5:30 AM PDT
About Us
Learn about who we are, what we believe
and the people who lead us
Our Story Serving patient needs is our passion; delivering revolutionary treatments is our mission
Our Leadership Our experienced leaders are bound by passion and science
Our Values We live our values of commitment, empowerment and teamwork
Our Responsibility Advancing a vision for change
Medical Affairs We are committed to advancing science and medicine through awareness, education and research
Our Focus
Discover our unique scientific approach
for diseases with high unmet need.
Our Therapies
The first and only FDA-approved
treatment for Demodex blepharitis
Our Pipeline
Explore the possibilities of our robust pipeline
to address significant unmet patient needs
Investors & News
Find additional corporate
and stock information.